South Bend man benefits from cancer breakthrough – South Bend Tribune
South Bend Tribune |
South Bend man benefits from cancer breakthrough
South Bend Tribune If that FDA approval comes — and UCM is preparing for it to come very soon — UCM will have one of the only facilities in the Midwest certified to administer chimeric antigen receptor T-cell infusion, or CAR T-cell, a newer form of immunotherapy. |
The CT Mirror |
Pioneering gene therapy gets green light — and $475000 price
The CT Mirror The country’s first approved gene therapy — approved Wednesday to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment, its manufacturer announced. Switzerland-based Novartis, which makes the innovative therapy … Has the Era of Gene Therapy Finally Arrived? – Scientific American …Scientific American (blog) First gene therapy that targets leukemia approved in the US …kwbe Gene therapy Kymriah: What’s in a name? | BioWorldBioWorld Online CNBC –KTRK-TV –The Pharma Letter (registration) all 36 news articles » |
WJBD Online |
First gene therapy that targets leukemia approved in the US
WJBD Online Called “CAR-T cell therapy,” it is the first gene therapy to enter the U.S. market. Novartis Pharmaceuticals priced the one-time infusion at $475,000. However, the company said it would waive costs for patients who didn’t respond to the treatment … |
KTIC |
First gene therapy that targets leukemia approved in the US | KTIC …
KTIC (NEW YORK) — The Food and Drug Administration has approved a landmark treatment that genetically modifies a patient’s blood cells to target and destroy … |
kwbe |
First gene therapy that targets leukemia approved in the US
kwbe Called “CAR-T cell therapy,” it is the first gene therapy to enter the U.S. market. Novartis Pharmaceuticals priced the one-time infusion at $475,000. However, the company said it would waive costs for patients who didn’t respond to the treatment … |